N -phenylpropyl- N ′-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice

Pharmacology Biochemistry and Behavior - Tập 150 - Trang 198-206 - 2016
Dennis K. Miller1,2, Eric S. Park2, Susan Z. Lever3,4, John R. Lever5,6
1Department of Psychological Sciences, University of Missouri, Columbia, MO 65211, USA
2Center for Translational Neuroscience, College of Medicine, University of Missouri, Columbia, MO 65211, USA
3Department of Chemistry, University of Missouri, Columbia, MO 65211, USA
4Research Reactor Center University of Missouri, Columbia, MO, 65211 USA
5Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO 65201, USA
6Department of Radiology, University of Missouri, Columbia, MO 65211, USA

Tài liệu tham khảo

Desai, 2005, Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs, J. Pharmacol. Exp. Ther., 315, 397, 10.1124/jpet.105.091231 Fujimoto, 2012, Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor, Synapse, 66, 630, 10.1002/syn.21549 Fujimura, 1997, Synthesis, structure and quantitative structure-activity relationships of sigma receptor ligands, 1-[2-(3.4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines, Bioorg. Med. Chem., 5, 1675, 10.1016/S0968-0896(97)00093-X Fujiwara, 1990, Effects of repeated administration of pentazocine on ambulatory activity in mice: comparison with the effects of morphine and methamphetamine, Jpn. J. Pharmacol., 54, 61, 10.1254/jjp.54.61 Hayashi, 2007, Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival, Cell, 131, 596, 10.1016/j.cell.2007.08.036 Hayashi, 2010, Regulation of σ-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats, J. Pharmacol. Exp. Ther., 332, 1054, 10.1124/jpet.109.159244 Katz, 2011, A role for sigma receptors in stimulant self administration and addiction, Pharmaceuticals (Basel), 4, 880, 10.3390/ph4060880 Lever, 1996, Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121), Nucl. Med. Biol., 23, 277, 10.1016/0969-8051(95)02074-8 Lever, 2006, σ1 and σ2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503, Synapse, 59, 350, 10.1002/syn.20253 Lever, 2012, Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N-4-phenethylpiperazine analogs, Nucl. Med. Biol., 39, 401, 10.1016/j.nucmedbio.2011.10.001 Lever, 2014, Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418, J. Pharmacol. Exp. Ther., 351, 153, 10.1124/jpet.114.216671 Lever, 2016, Cocaine occupancy of sigma1 receptors and dopamine transporters in mice, Synapse, 70, 98, 10.1002/syn.21877 Matsumoto, 2004, Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies, Pharmacol. Biochem. Behav., 77, 775, 10.1016/j.pbb.2004.01.014 Minabe, 1999, Acute and chronic administration of the selective σ1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study, Synapse, 33, 129, 10.1002/(SICI)1098-2396(199908)33:2<129::AID-SYN3>3.0.CO;2-E Mori, 2012, Inhibitory Effects of SA4503 on the Rewarding Effects of Abused Drugs, Addict. Biol. Nahas, 2008, Synthesis and structure-activity relationships of N-(3-phenylpropyl)-N′-benzylpiperazines: potent ligands for σ1 and σ2 receptors, Bioorg. Med. Chem., 16, 755, 10.1016/j.bmc.2007.10.037 Nguyen, 2005, Involvement of sigma (σ) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies, Neuropharmacology, 49, 638, 10.1016/j.neuropharm.2005.04.016 Patel, 2009, Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release, J. Neurosci., 29, 6568, 10.1523/JNEUROSCI.0181-09.2009 Reith, 1994, GBR 12909 and 12935 block dopamine uptake into brain synaptic vesicles as well as nerve endings, Eur. J. Pharmacol., 253, 175, 10.1016/0014-2999(94)90774-9 Rodvelt, 2010, Could sigma receptor ligands be a treatment for methamphetamine abuse?, Curr. Drug Abuse Rev., 3, 156, 10.2174/1874473711003030156 Rodvelt, 2011, The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine, Drug Alcohol Depend., 116, 203, 10.1016/j.drugalcdep.2010.12.018 Sage, 2012, What can rodent activity tell us about methamphetamine abuse?, 47 Sage, 2013, Effects of N-phenylpropyl-N′-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice, Pharmacol. Biochem. Behav., 110, 201, 10.1016/j.pbb.2013.07.006 Schmitt, 2010, Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse, Ann. N. Y. Acad. Sci., 1187, 316, 10.1111/j.1749-6632.2009.05148.x Uhl, 2002, Cocaine, reward, movement and monoamine transporters, Mol. Psychiatry, 7, 21, 10.1038/sj.mp.4000964 Xu, R., Lord, S.A., Peterson, R.M., Fergason-Cantrell, E.A., Lever, J.R., Lever, S.Z., 2015. Ether modifications to 1-[2-(3.4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters. Bioorg. Med. Chem., 23, 222–230.